INDGNIndegene Ltd.

    Indegene Ltd: results and news

    Every Indegene Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings, management change, mergers & acquisitions.

    3 articles · Healthcare marketing and technology services · Latest 29 Oct 2026

    INDGNIndegene Limited

    Indegene director Mark Dzialga resigns after Brighton Park Capital sells its entire stake

    Indegene Limited has told the exchanges that Mr. Mark Francis Dzialga, a Non-Executive Non-Independent Director, has resigned by a letter dated 14 Oct 2026, with effect from the close of business on 29 Oct 2026. The company says he gave the reason as the sale of the entire shareholding in the company held by Brighton Park Capital and its affiliated investment vehicles.

    • Management change
    • Life Sciences

    Blacklitt Research1 min read